Suchergebnisse - "Chong, Yong Pil"

PubPharm (292)

71

Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?

enthalten in: Infection | 2022

von Kim, H. | Seo, H. | Chung, H. | +11

72

Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?

enthalten in: Infection | 2022

von Kim, H. | Seo, H. | Chung, H. | +11

73

Bedside risk prediction for positive follow-up blood culture in Gram-negative bacilli bacteremia: for whom is follow-up blood culture useful?

enthalten in: Infection | 2022

von Kim, H. | Seo, H. | Chung, H. | +11

74

Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity

enthalten in: Open forum infectious diseases | 2022

von Seo, H. | Lee, J. | Ryu, S. | +12

75

Optimal duration of antiviral treatment in patients with gastrointestinal cytomegalovirus disease at a low and high risk of relapse

enthalten in: Medicine | 2022

von Jung, K. | Jung, J. | Kim, M. | +5

76

Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients

enthalten in: European journal of clinical microbiology & infectious diseases | 2022

von Lee, Y. | Lim, S. | Jung, J. | +6

77

Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients

enthalten in: European journal of clinical microbiology & infectious diseases | 2022

von Lee, Y. | Lim, S. | Jung, J. | +6

78

Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients

enthalten in: European journal of clinical microbiology & infectious diseases | 2022

von Lee, Y. | Lim, S. | Jung, J. | +6

79

Development of a new pharmacokinetic model for target‐concentration controlled infusion of vancomycin in critically ill patients

enthalten in: Clinical and Experimental Pharmacology and Physiology | 2022

von Bang, J. | Kang, H. | Lee, H. | +5

80

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers

enthalten in: Clinical and Translational Medicine | 2022

von Lim, S. | Jung, J. | Kim, J. | +17